Close

UPDATE: Berenberg Starts Recursion Pharmaceuticals (RXRX) at Buy

September 21, 2021 6:07 AM EDT Send to a Friend
(Updated - September 21, 2021 6:07 AM EDT)

Berenberg analyst Gal Munda initiates coverage on Recursion Pharmaceuticals (NASDAQ: RXRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login